María José Larráyoz

Author

María José Larráyoz

Also Known As

A. Manubens, Larráyoz, María José, M J Larrayoz, M J Larráyoz, M. J. Larrayoz, M. J. Larráyoz, M. Jose Larrayoz, M.J. Larrayoz, M.J. Larráyoz, Ma José Larráyoz

129

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

Universidad de Navarra Centro de Investigación Biomédica en Red de Cáncer Instituto de Investigación Biomédica de Salamanca Centro de Investigación del Cáncer Hospital Universitario 12 De Octubre

About

María José Larráyoz is an author at Universidad de Navarra specializing in medicine, molecular diagnostics, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	15	743
2	Health Sciences	3	3	147
3	Natural Sciences	3	3	168
4	Engineering	2	2	87
5	Blood Transplantation	1	1	13

María José Larráyoz

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasm Juliane Menezes, Francesco Acquadro, Michele S. Wiseman, Leukemia Hematological MalignancyRecurrent MutationsMedicineExome Sequencing RevealsMyeloid Neoplasia	2013	161
Response to lenalidomide in myelodysplastic syndromes with del(5q): influence of cytogenetics and mutations Mar Mallo, Mónica Del Rey, Mariam Ibáñez, British Journal of Haematology GeneticsImmunodeficienciesGenetic EpidemiologyImmunologyPathology	2013	83
Methylation of CpG dinucleotides and/or CCWGG motifs at the promoter of TP53 correlates with decreased gene expression in a subset of acute lymphoblastic leukemia patients Xabier Agirre, J.L. Vizmanos, Marı́a José Calasanz, Oncogene ChromatinCcwgg MotifsNatural SciencesEpigenetic ChangeDna Methylation	2003	82
Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma Marta Larráyoz, María J. García‐Barchino, Jon Celay, Nature Medicine	2023	75
<i>TP53</i> is frequently altered by methylation, mutation, and/or deletion in acute lymphoblastic leukaemia Xabier Agirre, Francisco J. Novo, Marı́a José Calasanz, Molecular Carcinogenesis	2003	69
Endogenous Retroelement Activation by Epigenetic Therapy Reverses the Warburg Effect and Elicits Mitochondrial-Mediated Cancer Cell Death Vicente Fresquet, María J. García‐Barchino, Marta Larráyoz, Cancer Discovery	2020	68
Prognostic value of FLT3 mutations in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy Eva Barragán, Pau Montesinos, Mireia Camós, Haematologica	2011	63
Mutation Patterns of 16 Genes in Primary and Secondary Acute Myeloid Leukemia (AML) with Normal Cytogenetics Marta Fernández‐Mercado, Bon Ham Yip, Andrea Pellagatti, PLoS ONE EngineeringMixed-phenotype Acute LeukemiaGeneticsMolecular GeneticsMutation Patterns	2012	62
<b> <i>NIN</i> </b>, a Gene Encoding a CEP110-Like Centrosomal Protein, Is Fused to <b> <i>PDGFRB</i> </b> in a Patient with a t(5;14)(q33;q24) and an Imatinib-Responsive Myeloproliferative Disorder J.L. Vizmanos, Francisco J. Novo, José P. Román, Cancer Research	2004	61
Aberrant DNA methylation profile of chronic and transformed classic Philadelphia-negative myeloproliferative neoplasms Cristina Pérez, Marién Pascual, José I. Martı́n-Subero, Haematologica Epigenetic ChangeGeneticsDna MethylationMixed-phenotype Acute LeukemiaPathology	2013	55

Page 1